Subscribe to the Newsletter
Stay informed about all developments and new formulations
FLUCOCAPS therapy
FLUCOCAPS therapy 150MG/CAP BTX7
Active ingredient: FLUCONAZOLE
ATC Classification: ANTIFUNGALS FOR SYSTEMIC USE
ATC Classification: ANTIFUNGALS FOR SYSTEMIC USE
Description
Medicine against fungal infections
- Cryptococcal infections, including cryptococcal meningitis and infections of other sites
- Generalised candidiasis
- Deep-seated endemic fungal infections
- Mucosal candidiasis
- Genital candidiasis
- Dermatophytoses: foot, cutaneous, genital, thigh, multiple dandruff, onychomycosis, skin infections due to Candida
- Prevention of fungal infections in patients with neutropenia and malignant diseases
CHARACTERISTICS
- Active ingredient: fluconazole
- Drug Class: Antifungals for systemic use
- Pharmaceutical form: capsule
- Concentration: 150mg/ capsule
- Packaging: 1 ΒΟΧ *1 BLK * 7 capsules
- Positive List
PAL & SPC INFORMATION
Download package leaflet